SCHEMBL13669397

SCHEMBL13669397

CC(C)(C)c1ccc(-c2c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3c(-c3ccc(C(C)(C)C)cc3)c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PPARG P37231 4/20 0.40
PPARA Q07869 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KMT2A Q03164 2/20 0.36
HDAC4 P56524 1/20 0.36
PTGES O14684 1/20 0.35
KIF11 P52732 2/20 0.35
PMM2 O15305 1/20 0.35
MPI P34949 1/20 0.35
PHOSPHO1 Q8TCT1 1/20 0.35
SERPINE1 P05121 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
TSPO P30536 1/20 0.33
DNM1 Q05193 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11910787 1.00 KDM4E (0.41) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13761983 0.96 PPARG (0.38) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13761986 0.96 PPARG (0.38) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13761982 0.96 KDM4E (0.42) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13761981 0.96 KDM4E (0.42) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL15080243 0.96 KDM4E (0.42) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL11910813 0.95 KDM4E (0.42) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13669286 0.95 KDM4E (0.42) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL12461805 0.93 KDM4E (0.44) KDM4EATML3MBTL1PPARGPPARA
SCHEMBL13761721 0.93 KDM4E (0.44) KDM4EATML3MBTL1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9257654-B2 Anthracene derivative, light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-02-09 US disclosed
US-20140081031-A1 Anthracene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-20 US disclosed
US-20140081031-A1 Anthracene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-20 US disclosed
WO-2009131199-A1 ANTHRACENE DERIVATIVE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPLIANCE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-10-29 WO disclosed
US-20090267498-A1 Anthracene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090267498-A1 Anthracene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance AP2A1, ABCE1, SLC35E1 KDM4E 2359/4885ATM 866/4885L3MBTL1 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.